{"id":429600,"date":"2025-12-06T21:27:16","date_gmt":"2025-12-06T21:27:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/429600\/"},"modified":"2025-12-06T21:27:16","modified_gmt":"2025-12-06T21:27:16","slug":"blood-pressure-drug-recalled-for-possible-cross-contamination","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/429600\/","title":{"rendered":"Blood pressure drug recalled for possible cross-contamination"},"content":{"rendered":"

Thousands of bottles of a commonly used prescription drug<\/a> to treat hypertension<\/a> has been recalled for possible contamination with another drug.<\/p>\n

Glenmark Pharmaceuticals Inc.<\/a>, which has U.S. headquarters<\/a> in Elmwood Park, New Jersey, has recalled multiple lots of bisoprolol fumarate and hydrochlorothiazide tablets (brand name Ziac<\/a>), because the tablets may have been cross contaminated with other products, according to a recall report published online by the Food and Drug Administration<\/a>.<\/p>\n

The global drug maker, which is headquartered in Mumbai, India, said testing of reserve samples showed presence of traces of ezetimibe, a cholesterol drug the company also produces, according to the recall, posted Dec. 1.<\/p>\n

Vaccine directive: <\/strong>RFK Jr. panel ends recommendation of hepatitis b vaccine for newborns<\/a><\/p>\n

The FDA classified the recall with a Class III risk level<\/a>, which suggests “use of or exposure to a violative product is not likely to cause adverse health consequences,” according to the agency.<\/p>\n

Bisoprolol\/hydrochlorothiazide blocks beta-1 receptors in your heart, allowing the heart to beat normally, according to WebMD<\/a>. The drug also increases urination to remove sodium and water from the body, as well as relaxes blood vessels \u2013 to help lower blood pressure and help to reduce heart attack and stroke risk.<\/p>\n

USA TODAY Recall Database: <\/strong>Search vehicle, product and food recalls<\/a><\/p>\n

What blood pressure medicine is being recalled?<\/p>\n

The recall involves an undeclared number of lots of tablets, from 2.5 mg to 6.25 mg dosages, in various sized bottles, manufactured in Madhya Pradesh, India for Glenmark Pharmaceuticals, Inc., USA.<\/p>\n

These lots were recalled:<\/p>\n